Key Considerations for Maximizing LV and AAV Production in Transient Transfection Workflows
"Key Considerations for Maximizing LV and AAV Production in Transient Transfection Workflows." Presented by Leisha Kopp, Applications Scientist, Mirus Bio.
BioProcess International Ask the Expert 2021.
Видео Key Considerations for Maximizing LV and AAV Production in Transient Transfection Workflows канала BioProcess International
BioProcess International Ask the Expert 2021.
Видео Key Considerations for Maximizing LV and AAV Production in Transient Transfection Workflows канала BioProcess International
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
PANEL DISCUSSION Emerging Bio Therapies and Their Manufacturing ChallengesStrategies for Implementing New Technologies in an Outsourcing Environment: A Roundtable DiscussionReducing Risk and Improving Timelines in the Design, Development, and Manufacture of Antibody...Aseptic Filling for Gene Therapies and Next Generation Biologics Within Closed Robotic WorkcellsCRISPR Library Screens for Oncology Target DiscoveryEvaluation of the "Scale-Out" Biomanufacturing Strategy from Early Clinical...Exploring New and Improved Analytical Methods for Traditional and Unique ModalitiesMeeting Regulatory Requirements for Cell and Gene Therapy ManufacturingAddressing Purification Challenges for Complex Therapeutics with Custom Chromatography ResinsPractical Approaches to Metals Analysis of Cell Culture MediaThe Critical Steps for Protein Therapeutic Potency Assay DevelopmentDownstream Processing with Giorgio CartaChina's GMP Strategies: Dealing with Quality Management Issues, to Compete with the WestHow to Halve the Costs of Antibody Purification?Translating Inhaled and Nasal Technologies for the Delivery of BiologicsBioprocess 101 – Cell Culture Media AnalysisUnderstanding Viral Clearance During Anion Exchange Chromatography by Using a Novel Design of...Securing Your Manufacturing Capacity During a PandemicBioconjugation CMC: Successfully Executing a Complex ProcessImproving and Intensifying Vaccine Purification By Implementing Affinity Chromatography